Literature DB >> 21616973

Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors.

Diego N Kaski1, Catherine Pennington, Jon Beck, Mark Poulter, James Uphill, Matthew T Bishop, Jaqueline M Linehan, Catherine O'Malley, Jonathan D F Wadsworth, Susan Joiner, Richard S G Knight, James W Ironside, Sebastian Brandner, John Collinge, Simon Mead.   

Abstract

Genetic factors are implicated in the aetiology of sporadic late-onset neurodegenerative diseases. Whether these genetic variants are predominantly common or rare, and how multiple genetic factors interact with each other to cause disease is poorly understood. Inherited prion diseases are highly heterogeneous and may be clinically mistaken for sporadic Creutzfeldt-Jakob disease because of a negative family history. Here we report our investigation of patients from the UK with four extra octapeptide repeats, which suggest that the risk of clinical disease is increased by a combination of the mutation and a susceptibility haplotype on the wild-type chromosome. The predominant clinical syndrome is a progressive cortical dementia with pyramidal signs, myoclonus and cerebellar abnormalities that closely resemble sporadic Creutzfeldt-Jakob disease. Autopsy shows perpendicular deposits of prion protein in the molecular layer of the cerebellum. Identity testing, PRNP microsatellite haplotyping and genealogical work confirm no cryptic close family relationships and suggests multiple progenitor disease haplotypes. All patients were homozygous for methionine at polymorphic codon 129. In addition, at a single nucleotide polymorphism upstream of PRNP thought to confer susceptibility to sporadic Creutzfeldt-Jakob disease (rs1029273), all patients were homozygous for the risk allele (combined P=5.9×10(-5)). The haplotype identified may also be a risk factor in other partially penetrant inherited prion diseases although it does not modify age of onset. Blood expression of PRNP in healthy individuals was modestly higher in carriers of the risk haplotype. These findings may provide a precedent for understanding apparently sporadic neurodegenerative diseases caused by rare high-risk mutations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21616973     DOI: 10.1093/brain/awr079

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  12 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 2.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

Review 3.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

Review 4.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

Review 5.  Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.

Authors:  Giuseppe Scalabrino; Daniela Veber
Journal:  J Neurol       Date:  2013-10-20       Impact factor: 4.849

6.  Predictive testing for inherited prion disease: report of 22 years experience.

Authors:  Jane Owen; Jon Beck; Tracy Campbell; Gary Adamson; Michele Gorham; Andrew Thompson; Sarah Smithson; Elizabeth Rosser; Peter Rudge; John Collinge; Simon Mead
Journal:  Eur J Hum Genet       Date:  2014-04-09       Impact factor: 4.246

7.  Familial Creutzfeldt-Jakob Disease in an Indian Kindred.

Authors:  Sarosh M Katrak; Apoorva Pauranik; Shrinivas B Desai; Simon Mead; Jon Beck; Sebastian Brandner; John Collinge
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

8.  Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease.

Authors:  E De Vita; G R Ridgway; R I Scahill; D Caine; P Rudge; T A Yousry; S Mead; J Collinge; H R Jäger; J S Thornton; H Hyare
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-28       Impact factor: 3.825

Review 9.  Genetics of prion diseases.

Authors:  Sarah E Lloyd; Simon Mead; John Collinge
Journal:  Curr Opin Genet Dev       Date:  2013-03-19       Impact factor: 5.578

10.  Spontaneous generation of prions and transmissible PrP amyloid in a humanised transgenic mouse model of A117V GSS.

Authors:  Emmanuel A Asante; Jacqueline M Linehan; Andrew Tomlinson; Tatiana Jakubcova; Shyma Hamdan; Andrew Grimshaw; Michelle Smidak; Asif Jeelani; Akin Nihat; Simon Mead; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  PLoS Biol       Date:  2020-06-09       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.